Summary
Coronary stents, which include bare metal stents, drug-eluting stents (DESes), covered stents, and bioabsorbable stents (BASes)
De novo stenosis, acute myocardial infarction (AMI), bifurcation lesions, small vessel disease (SVD), saphenous vein grafts (SVGs), left main coronary artery disease (LMCAD), and chronic total occlusions (CTOs)
In the US and 5EU, coronary stents market value is expected to decline slowly, whereas it is expected to demonstrate steady growth in the APAC and South American regions
Newer technologies, such as BASes and the third generation of DESes aim to address unmet needs of complex lesions and challenging populations
Browse Full Report with TOC @ http://www.radiantinsights.com/research/medipoint-percutaneous-coronary-interventions-global-analysis-and-market-forecasts
The development and commercialization of the next generation of DESes with innovative platforms indicates the continued value of DESes in the coronary market
The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Medtronic, and Boston Scientific
Other key players include B. Braun, Biosensors International, Biotronik, and Terumo as they develop innovative coronary stent platforms.
Highlights
Key Questions Answered
- What is the current and future percutaneous coronary interventions market outlook in the developed and emerging markets? What trends are affecting the global market?
- Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with the current generation of devices? How will emerging technologies such as bioabsorbable stents and drug-eluting stents fulfill these unmet needs?
- What is the physician perception of these new technologies? Which indications have been treated most successfully using minimally invasive treatments?
- What are the challenges and complications that have hindered widespread adoption?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global percutaneous coronary interventions market?
Key Findings
- Growth in the percutaneous coronary interventions market will be driven primarily by rising procedure volumes, the increasing global prevalence of coronary artery disease, and as rising rates of diabetes in particular.
- The introduction of Bioabsorbable stents (BASes) can reduce or even eliminate the prolonged use of DAPT; as long-term clinical efficacy data become available, clinicians will prefer to use BASes over drug-eluting stents (DESes).
- Bioabsorbable stents (BASes) are also expected to see fast adoption as they are introduced across major markets, as they have the potential to significantly reduce restenosis rates and allow for vessel remodeling.
- The current key players will need to retain and acquire market share by improving the clinical performance of their existing products.
See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/medical-devices
About Radiant Insights, Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Web: http://www.radiantinsights.com/
Coronary stents, which include bare metal stents, drug-eluting stents (DESes), covered stents, and bioabsorbable stents (BASes)
De novo stenosis, acute myocardial infarction (AMI), bifurcation lesions, small vessel disease (SVD), saphenous vein grafts (SVGs), left main coronary artery disease (LMCAD), and chronic total occlusions (CTOs)
In the US and 5EU, coronary stents market value is expected to decline slowly, whereas it is expected to demonstrate steady growth in the APAC and South American regions
Newer technologies, such as BASes and the third generation of DESes aim to address unmet needs of complex lesions and challenging populations
Browse Full Report with TOC @ http://www.radiantinsights.com/research/medipoint-percutaneous-coronary-interventions-global-analysis-and-market-forecasts
The development and commercialization of the next generation of DESes with innovative platforms indicates the continued value of DESes in the coronary market
The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Medtronic, and Boston Scientific
Other key players include B. Braun, Biosensors International, Biotronik, and Terumo as they develop innovative coronary stent platforms.
Highlights
Key Questions Answered
- What is the current and future percutaneous coronary interventions market outlook in the developed and emerging markets? What trends are affecting the global market?
- Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with the current generation of devices? How will emerging technologies such as bioabsorbable stents and drug-eluting stents fulfill these unmet needs?
- What is the physician perception of these new technologies? Which indications have been treated most successfully using minimally invasive treatments?
- What are the challenges and complications that have hindered widespread adoption?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global percutaneous coronary interventions market?
Key Findings
- Growth in the percutaneous coronary interventions market will be driven primarily by rising procedure volumes, the increasing global prevalence of coronary artery disease, and as rising rates of diabetes in particular.
- The introduction of Bioabsorbable stents (BASes) can reduce or even eliminate the prolonged use of DAPT; as long-term clinical efficacy data become available, clinicians will prefer to use BASes over drug-eluting stents (DESes).
- Bioabsorbable stents (BASes) are also expected to see fast adoption as they are introduced across major markets, as they have the potential to significantly reduce restenosis rates and allow for vessel remodeling.
- The current key players will need to retain and acquire market share by improving the clinical performance of their existing products.
See More Reports of This Category by Radiant Insights @ http://www.radiantinsights.com/catalog/medical-devices
About Radiant Insights, Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Web: http://www.radiantinsights.com/
No comments:
Post a Comment